Organon & Co.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $6.2B | $6.4B | $6.3B | $6.2B | $6.3B |
| Gross profit | $3.3B | $3.7B | $3.7B | $3.9B | — |
| Cost of revenue | $2.9B | $2.7B | $2.5B | $2.3B | $2.4B |
| Cash from operations | $700.0M | $939.0M | $799.0M | $858.0M | $2.2B |
| Capital expenditure | $162.0M | $175.0M | $251.0M | $196.0M | $192.0M |
| Free cash flow | $538.0M | $764.0M | $548.0M | $662.0M | $2.0B |
| Impairments | $301.0M | $0 | $0 | $9.0M | $7.0M |
| Total assets | $12.9B | $13.1B | $12.1B | $11.0B | $10.7B |
| Total liabilities | $12.1B | $12.6B | $12.1B | $11.8B | — |
Shares outstanding 262.6M · Free float 98.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.